Adekeye A, Agarwal D, Nayak A, Tchou J (2022) PTGES3 is a putative prognostic marker in breast cancer. J Surg Res 271:154–162. https://doi.org/10.1016/j.jss.2021.08.033

Article  CAS  PubMed  Google Scholar 

Ayiomamitis GD, Notas G, Vasilakaki T, Tsavari A, Vederaki S, Theodosopoulos T, Kouroumalis E, Zaravinos A (2019) Understanding the interplay between COX-2 and hTERT in colorectal cancer using a multi-Omics analysis. Cancers 11:1536. https://doi.org/10.3390/cancers11101536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badr H, Blutrich R, Chan K, Tong J, Taylor P, Zhang W, Kafri R, Röst HL, Tsao MS, Moran MF (2022) Proteomic characterization of a candidate polygenic driver of metabolism in non-small cell lung cancer. J Mol Biol 434:167636. https://doi.org/10.1016/j.jmb.2022.167636

Article  CAS  PubMed  Google Scholar 

Bi Z, Zhang W, Yan X (2022) Anti-inflammatory and immunoregulatory effects of icariin and icaritin. Biomed Pharmacother 151:113180. https://doi.org/10.1016/j.biopha.2022.113180

Article  CAS  PubMed  Google Scholar 

Braden AM, Stankowski RV, Engel JM, Onitilo AA (2014) Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des 20:4879–4898. https://doi.org/10.2174/1381612819666131125145517

Article  CAS  Google Scholar 

Cecconi D, Carbonare LD, Mori A, Cheri S, Deiana M, Brandi J, Degaetano V, Masiero V, Innamorati G, Mottes M, Malerba G, Valenti MT (2017) An integrated approach identifies new oncotargets in melanoma. Oncotarget 9:11489–11502. https://doi.org/10.18632/oncotarget.23727

Article  PubMed  PubMed Central  Google Scholar 

Dong C, Shi J, Chen X, Zhou J, Liu Y, Zhao J, Ma C, Fan Q (2019) Beneficial effects of Herba Epimedii on ovariectomized rats by down-regulating PGE2 and ADRbeta-2R expression. Minerva Med 110:595–597. https://doi.org/10.23736/S0026-4806.19.06060-9

Article  PubMed  Google Scholar 

Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast cancer in China. Lancet Oncol 115:e279–e289. https://doi.org/10.1016/S1470-2045(13)70567-9

Article  Google Scholar 

Gao P, Zou K, Xiao L, Zhou H, Xu X, Zeng Z, Zhang W (2022) High expression of PTGES3 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Int Immunopharmacol 110:108954. https://doi.org/10.1016/j.intimp.2022.108954

Article  CAS  PubMed  Google Scholar 

He Y, Peng S, Wang J, Chen H, Cong X, Chen A, Hu M, Qin M, Wu H, Gao S, Wang L, Wang X, Yi Z, Liu M (2016) Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nat Commun 7:13122. https://doi.org/10.1038/ncomms13122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong W, Dong E (2014) The past, present and future of breast cancer research in China. Cancer Lett 351:1–5. https://doi.org/10.1016/j.canlet.2014.04.007

Article  CAS  PubMed  Google Scholar 

Huang C, Chen X, Guo B, Huang W, Shen T, Sun X, Xiao P, Zhou Q (2012) Induction of apoptosis by icariside II through extrinsic and intrinsic signaling pathways in human breast cancer MCF7 cells. Biosci Biotechnol Biochem 76:1322–1328. https://doi.org/10.1271/bbb.120077

Article  CAS  PubMed  Google Scholar 

Jiang J, Jiang S, Ahumada-Canale A, Chen Z, Si L, Jiang Y, Yang L, Gu Y (2023) Breast cancer screening should embrace precision medicine: evidence by reviewing economic evaluations in China. Adv Ther 40:1393–1417. https://doi.org/10.1007/s12325-023-02450-z

Article  PubMed  PubMed Central  Google Scholar 

Katsura C, Ogunmwonyi I, Kankam HK, Saha S (2022) Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond) 83:1–7. https://doi.org/10.12968/hmed.2021.0459

Article  PubMed  Google Scholar 

Kim B, Park B (2014) Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression. Biochemistry 53:7562–7569. https://doi.org/10.1021/bi5011927

Article  CAS  PubMed  Google Scholar 

Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B, Burdan F (2017) Primary and secondary prevention of breast cancer. Ann Agric Environ Med 24:549–553. https://doi.org/10.26444/aaem/75943

Article  PubMed  Google Scholar 

Li T, Mello-Thoms C, Brennan PC (2016) Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat 159:395–406. https://doi.org/10.1007/s10549-016-3947-0

Article  CAS  PubMed  Google Scholar 

Li YL, Qin YC, Tang LY, Liao YH, Zhang W, Xie XM, Liu Q, Lin Y, Ren ZF (2019) Patient and care delays of breast cancer in China. Cancer Res Treat 51:1098–1106. https://doi.org/10.4143/crt.2018.386

Article  PubMed  Google Scholar 

Liang Y, Liu M, Wang P, Ding X, Cao Y (2013) Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in non-small-cell lung cancer. Genes Chromosom Cancer 52:305–315. https://doi.org/10.1002/gcc.22030

Article  CAS  PubMed  Google Scholar 

Libson S, Lippman M (2014) A review of clinical aspects of breast cancer. Int Rev Psychiatry 26:4–15. https://doi.org/10.3109/09540261.2013.852971

Article  PubMed  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262

Article  CAS  PubMed  Google Scholar 

Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B (2018) Inflammatory breast cancer: what to know about this unique, aggressive breast cancer. Surg Clin North Am 98:787–800. https://doi.org/10.1016/j.suc.2018.03.009

Article  PubMed  Google Scholar 

Pace LE (2022) Risk-based approaches to breast cancer screening in China. JAMA Netw Open 5:e2241448. https://doi.org/10.1001/jamanetworkopen.2022.41448

Article  PubMed  Google Scholar 

Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S (2014) Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification. Int J Oncol 45:1829–1836. https://doi.org/10.3892/ijo.2014.2605

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peairs KS, Choi Y, Stewart RW, Sateia HF (2017) Screening for breast cancer. Semin Oncol 44:60–72. https://doi.org/10.1053/j.seminoncol.2017.02.004

Article  PubMed  Google Scholar 

Song J, Feng L, Zhong R, Xia Z, Zhang L, Cui L, Yan H, Jia X, Zhang Z (2017) Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-kappaB signaling pathway. Mol Carcinog 56:36–48. https://doi.org/10.1002/mc.22471

Article  CAS  PubMed  Google Scholar 

Sun L, Legood R, Sadique Z, Dos-Santos-Silva I, Yang L (2018) Cost-effectiveness of risk-based breast cancer screening programme, China. Bull World Health Organ 96:568–577. https://doi.org/10.2471/BLT.18.207944

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Wang N, Huang X, Yang B, Zheng Y, Zhang J, Wang X, Lin Y, Wang Z (2020) Baohuoside I suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway. Phytomedicine 78:153331. https://doi.org/10.1016/j.phymed.2020.153331

Article  CAS  PubMed  Google Scholar